Search results for " costs"
Article
CMOs Concerned With Cost of Single-Use Equipment
Is single-use too expensive?
The relatively rapid growth in use of single-use equipment for early-stage (and increasingly commercial stage) manufacturing may suggest that costs are considered reas…
Article
Cost Considerations Drive Lean Technology in Biopharmaceutical Manufacturing
By Catherine Shaffer
Four biosimilars have been approved for the market by FDA as of February 2017, and more are in the pipeline. Now that biosimilars are here to stay, manufacturers are devel…
Article
The Extreme Costs of a Bioburden Incident
The cost of bioburden incidents can vastly outweigh the costs of preventing them. Read the bioburden article series.
Article
Drugs, At What Cost?
Competition generated through established biosimilar pathways will drive down the high costs of biologics in Europe, the US, and some emerging countries. However, in markets with less rigorous IP prot…
Article
Biomanufacturing: The Cost of Unskilled Workers
Strategies your company should consider for recruiting, training and retaining staff
Several trends shaping the future of biopharma will have a direct impact on workforce development. F…
Article
Make buffer preparation more time and cost efficient with inline conditioning
Simplify Buffer Preparation
The volume and number of buffers for a typical downstream process can be considerable.
Preparation of these buffers is a challenge that in-line conditioning can o…
Article
Modular Manufacturing Platforms for Biologics
Using the same equipment for development and manufacturing could help minimize technical transfer costs and resources, he wrote in his PDA presentation notes, and could reduce inventory overheard whil…
Article
Continuous Manufacturing: A Changing Processing Paradigm
Other advantages of continuous manufacturing include consistent product quality; smaller equipment; streamlined processes; low process cycle times; reduced operating costs; increased flexibility; elim…
Article
The Affordable Care Act's Impact on Innovation in Biopharma
Impact of Shifting Risk
With the ACA’s endorsement of ACOs, there is a clear emphasis on shifting risk associated with the quality and costs of healthcare to the provider. The focus on the ACO mod…
Article
Managing Biomanufacturing Capacity Expectations
A 2007 article in Pharmaceutical Executive estimated that a launch delay costs an average of $15 million per drug per day (4). This number changes, however, depending on the market demand of the drug …